Navigation Links


Monoclonal in Medical News

Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors

Antibody Targets Endosialin, a Protein Widely Expressed on Tumors and Tumor Blood Vessel Cells EXTON, Pa., June 9 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new ...

Intellect Neurosciences, Inc. Validates Pivotal European Patent for Alzheimer's Monoclonal Antibody Platform

Follows Option and Royalty-Bearing License Agreements with Top Tier Global Pharmaceutical Companies NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents...

Biosimilar Monoclonal Antibodies in Oncology Will Approach Blockbuster Status by 2017

Opportunity for Biosimilars Varies Significantly by Therapeutic Area, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds ...

The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016

Market Will be Driven by Increasing Use of Established Agents That Include Avastin, Erbitux, Rituxan/MabThera, According to a New Report from Decision Resources WALTHAM, Mass., June 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advi...

Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.

BURLINGAME, Calif., May 6 /PRNewswire/ -- Epitomics, Inc. announced today that its Hangzhou subsidiary has received ISO 9001-2000 certification for the development and production of its novel line of rabbit monoclonal antibodies. "This certification demonstrates our commitment to establishing ...

Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product

GAITHERSBURG, Md., Dec. 5 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. announced today the selection of PAN-622 -- a fully human sequence monoclonal antibody against HAAH -- as its lead cancer therapeutic product. Developed in collaboration with the Massachusetts Institute of Technology, PAN-...

A New Monoclonal Antibody Kills Cancer Cells

Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics. Using a newly available monoclonal antibody, they demonstrated significant redu...

Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies

According to a study done by Kate Rittenhouse-Olson, Ph.D., the monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend// significantly the survival of mice with human breast-cancer tumors. The study also finds that the antibody inhibits the cancer's s...

Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs

New study has suggested that therapeutics based on monoclonal antibodies (mAbs) are fare more likely to be commercially successful than their small molecule predecessors. According to a study completed by // consultancy Propagate Pharma, about half the mAbs launched so fare appear to be profitable....

Micromet, Inc. Reports Second Quarter 2009 Financial Results

...eveloped from the currently marketed EGFR-specific monoclonal antibodies Erbitux(R) (cetuximab) and Vectibix(R) ...ome the resistance of mutated tumor cells to those monoclonal antibodies. Micromet also presented data at the AA... 2009 on a phase 1b combination study of its human monoclonal antibody adecatumumab with docetaxel in patients w...

DSM Announces SafeBridge(R) Potent Compound Safety Certification

...opment, registered intermediates, registered starting materials, active pharmaceutical ingredients (API's), fermentation, mammalian cell production of monoclonal antibodies and proteins, formulation development, clinical trial manufacturing and finished dose form manufacturing of solids, semi-solids, and schedu...

PDL BioPharma Elects Barry Selick to Its Board of Directors

...ociety Senior Fellow at the University of California, San Francisco. About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on m...

PDL BioPharma Announces Second Quarter 2009 Financial Results

...o the call to allow for any software download that may be necessary. About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on m...

JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab

... A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial antitumor activity in ovarian cancer cell lines and in mice, according to a study published...

Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...

Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition

...uth African National Parks 3rd Place for Wildlife, $1,500 Santiago Diaz, University of Florida D07ZO-607 : "Use of Elephant-Specific monoclonal Antibodies and Recombinant Antigens of Mycobacterium tuberculosis to Improve an ELISA Test for Elephants" IMPACT Award, $500 Ana Iris Mot...

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim((R)) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia((R)) - a novel bioscavenger for the prevention and treatment of morbidit...

Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...

PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009

...e call to allow for any software download that may be necessary. About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on m...

UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...

Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...

Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...final ruling. The company began enrolling patients in two separate but identical Phase III clinical trials of solanezumab, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease. The trials each include a treat...

New Alzheimer's Treatment Could Be on the Horizon

...ving the immune system a boost and slowing down, or preventing, the buildup of the toxic plaque. Several drug companies are also at work developing monoclonal antibodies, or artificially produced drugs, to prevent the beta-amyloid buildup. Despite the study's promising results, the researchers said, they'...

Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)

...included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and/or persistence of the reaction, permanently disco...

QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement

...tform technology for the generation of fully human monoclonal antibodies, and QuikByte Software, Inc. (OTC Bulle...etary technology for the generation of fully human monoclonal antibodies." Glenn L. Halpryn stated "We ...licable platform for the generation of fully human monoclonal antibodies based on its proprietary technology. So...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

... 431883#. About Peregrine Pharmaceuticals Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in ca...

Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows

...rmed by chemical methods that the fluorescent probes were indeed binding to caspases. Next, the team performed experiments with a new, experimental monoclonal antibody that activates caspases, by a mechanism different from that of dexamethasone, and initiates apoptosis particularly in rapidly dividing cells ...

New Drug Fights Anthrax Toxin

...ble anthrax attack, researcher says,, WEDNESDAY, July 8 (HealthDay News) -- Scientists report that experiments in animals show that a new, monoclonal antibody drug might safely cure anthrax poisoning in humans. Although antibiotics can kill the anthrax bacteria, they are not effective in killing ...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

... Targeted Therapy II-34 Gene Therapy II-34 Immunotherapy II-34 monoclonal Antibody Treatment II-35 Vaccines II-35 Donor Lymphocyte Infusion I...er Plans Acquisition of ViaCell II-51 Favrille Announces Acquisition of monoclonal Antibody Range from Diversa II-52 Johnson & Johnson Secures Con...

Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemia

...able progress in the understanding of what initiates and sustains cancer. Together with his collaborators Dr. Dick has developed the first anti-cancer monoclonal antibody therapy that specifically targets cancer stem cells. This discovery offers hope for the development of treatments that target the cancer stem...

Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial

...nd follow-up are continuing. Bavituximab is a monoclonal antibody with a unique mechanism that enables the ...rget for anti-cancer treatments. Bavituximab is a monoclonal antibody that binds specifically to these phosphol...rmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of...

MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost

...ederal Poverty Level (FPL) guidelines established by the U.S. Department of Health and Human Services (HHS). Synagis is a biologic medicine known as a monoclonal antibody administered monthly to high-risk infants to prevent serious lower respiratory tract infection caused by respiratory syncytial virus (RSV), a...

Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm

...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform

... a unique target for cancer diagnostics and therapeutics. Bavituximab is a monoclonal antibody that specifically targets PS exposed on the surface of the cells l...uticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral...

Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease

...lly fatal, and include deafness and amyloidosis resulting in renal failure and early death. Ilaris, previously known as ACZ885, is a fully human monoclonal antibody that rapidly and selectively blocks interleukin-1 beta (IL-1 beta). The dosing schedule for Ilaris is once every eight weeks, which is less f...

Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203

...BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class ...erexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also binds to EpCAM ...patients with metastatic breast cancer. Micromet's monoclonal antibody MT293, also known as TRC093, is licensed ...

Access Pharmaceuticals Announces Initiation of Two New Cobalamin(TM) Oral Insulin Drug Delivery Collaborations

...echnology to deliver actives ranging from small molecules to siRNA to monoclonal antibodies . As siRNA needs to be delivered intracellularly to be effectiv...d on the natural vitamin B12 uptake mechanism; and Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breas...

New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimer's Disease Market

...nds that the launch and uptake of new anti-amyloid monoclonal antibodies, most notably Elan/Wyeth's bapineuzumab...lzheimer's disease market in 2018. While these two monoclonal antibodies are expected to offer superior efficacy...l and commercial promise are the anti-beta amyloid monoclonal therapies such as bapineuzumab and solanezumab, wh...

Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement

...nt for the production of Anthim(TM), a therapeutic monoclonal antibody in late stage development for the treatme...derable experience in large-scale manufacturing of monoclonal antibodies and a well-established reputation with ...thim is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of B...
Other TagsJacketStrapWrapStimStimStimStimStimATSATSATSATSATSATS
(Date:11/25/2009)...er 11, firefighters, police officers and ambulance...orld Trade Center complex. They battled to save pe... survivors, tackled fires and evacuated as many pe...stimated 17,000 people. And making their jobs even...ightened workers and their relatives jammed mobile...
(Date:11/25/2009)..., CAWhen you eat may be just as vital to your heal...Institute for Biological Studies. Their experiment...g of thousands of genes in the liverthe body,s met...ntake and not by the body,s circadian clock as con...ermines the activity of a large number of genes co...
(Date:11/24/2009)...t keep weakened and flabby arteries from collapsin..., those stents are no longer needed -- once the ar...Previously, doctors had no choice but to leave the... University,s Department of Biomedical Engineering... that carries drugs where they,re needed, then dis...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2Pence Amendment Passes Rules Committee 3B Set for Friday Vote 52628 1Pence Amendment Passes Rules Committee 3B Set for Friday Vote 52628 2Genomma Lab International Announces Second Quarter 2009 Results 52626 1Genomma Lab International Announces Second Quarter 2009 Results 52626 2Genomma Lab International Announces Second Quarter 2009 Results 52626 3Genomma Lab International Announces Second Quarter 2009 Results 52626 4Oprah Luke Skywalker and Maradona new study investigates how our brains respond to them 13180 1Oprah Luke Skywalker and Maradona new study investigates how our brains respond to them 13180 2Oprah Luke Skywalker and Maradona new study investigates how our brains respond to them 13180 3
(Date:11/29/2009)... Moravia,s Nanjing-based Service Deliver...ce , Brno, Czech Republic...tion solution provider, is pleased to announce its... 2009, to be held in Nanjing, China, on November 3...Union-based companies that have established and gr...
(Date:11/29/2009)... CA--New connections begin to form between brain c...k, according to a study published this week in Na...ifornia, Santa Cruz, the study involved detailed o...ace in the brain during motor learning. , The re...ch through a slot to get a seed. They observed rap...
(Date:11/29/2009)...aware the sleep disorder boosts urine production, ...Day News) -- People who wake up during the night t...al problem. Sleep apnea, a breathing-related sleep...ggests that nighttime urination, or nocturia, is c...ive sleep apnea, a disorder in which soft tissue i...
(Date:11/28/2009)...HICAGO, Nov. 28 Get ready for a... the clinical routine when Siemens introduces ...ly and Annual Meeting of the Radiological Society ...er 3 at McCormick Place (Booth #825, East Building...o. via , Siemens, new imaging software for mu...
(Date:11/27/2009)...DFORD, Mass., Nov. 27 GS...a supplier of precision technology products and se...l meeting of the Company,s shareholders has been s... location of the meeting will be announced in due ...ived a requisition notice from Stephen Bershad, a ...
Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
Other Contentscoscorticosteroidscorticosteroidscorticosteroidscosmidcosmidcouplingcouplingcouplingcouplingcouplingcouplingcouplingcotyledonsislandislandislandislandcraniumcranium